Update on Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 2000-2018.

IF 1.8 4区医学 Q3 ONCOLOGY

Cancer Investigation Pub Date : 2024-04-01 Epub Date: 2024-05-14 DOI:10.1080/07357907.2024.2353313

Guan Li, Jesse W Tai, Peter K Moon, Uchechukwu C Megwalu

引用次数: 0

Abstract

Thyroid cancer is the most common endocrine malignancy in the pediatric population. A recent study has revealed a recent decline in overall US thyroid cancer incidence rates. The aim of this study is to assess whether there has been a corresponding decline in incidence rates in the pediatric population. We used the Surveillance, Epidemiology, and End Results (SEER) database to analyze the pediatric thyroid cancer incidence rate. The results demonstrate that the incidence rate of pediatric thyroid cancer continued to increase from 2000 to 2018. Future studies are needed to understand how recent changes in guidelines are affecting incidence rates.

查看原文本刊更多论文

2000-2018年美国小儿甲状腺癌发病率和死亡率趋势的最新情况。

甲状腺癌是儿科人群中最常见的内分泌恶性肿瘤。最近的一项研究显示，美国甲状腺癌的总体发病率有所下降。本研究旨在评估儿科人群的发病率是否也出现了相应的下降。我们利用监测、流行病学和最终结果（SEER）数据库分析了儿科甲状腺癌的发病率。结果表明，从2000年到2018年，儿科甲状腺癌的发病率持续上升。未来还需要开展研究，以了解近期指南的变化如何影响发病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Investigation 医学-肿瘤学

CiteScore

3.80

自引率

4.20%

发文量

审稿时长

8.5 months

期刊介绍： Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.